Rodrigo Ruiz Soto
Hoofd Techniek/Wetenschap/O&O bij DECIPHERA PHARMACEUTICALS, INC.
Actieve functies van Rodrigo Ruiz Soto
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2017 | - |
| IMMUNOGEN, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Rodrigo Ruiz Soto
Eerdere bekende functies van Rodrigo Ruiz Soto
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Rodrigo Ruiz Soto
| Universidad Nacional Autónoma de México | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Mexico | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Retail Trade | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Beurs
- Insiders
- Rodrigo Ruiz Soto
- Ervaring